ABEO - Abeona Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

42.07M

Cash

40.36M

Avg Qtr Burn

-10.39M

Short % of Float

2.22%

Insider Ownership

2.85%

Institutional Own.

44.98%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
EB-101 (COL7A1) Details Recessive dystrophic epidermolysis bullosa	BLA Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ABO-102 (AAV-based Gene Therapy) Details Mucopolysaccharidosis type IIIA, Rare diseases, Rare genetic disease, Genetic disorder, Mucopolysaccharidoses	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ABO-101 (AAV-based Gene Therapy) Details Rare diseases, Rare genetic disease, Genetic disorder, Mucopolysaccharidoses, Mucopolysaccharidosis type IIIB	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.